Jeffrey L. Berenberg

8.3k total citations
63 papers, 1.7k citations indexed

About

Jeffrey L. Berenberg is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jeffrey L. Berenberg has authored 63 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 13 papers in Pathology and Forensic Medicine and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jeffrey L. Berenberg's work include Colorectal Cancer Treatments and Studies (9 papers), Genetic factors in colorectal cancer (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Jeffrey L. Berenberg is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Genetic factors in colorectal cancer (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Jeffrey L. Berenberg collaborates with scholars based in United States, Australia and Ukraine. Jeffrey L. Berenberg's co-authors include Peter A. Ward, Eva Culakova, Steven R. Alberts, Frank A. Sinicrope, Daniel J. Sargent, Richard M. Goldberg, Charles Kamen, Karen M. Mustian, Michelle C. Janelsins and Qian Shi and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

Jeffrey L. Berenberg

60 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey L. Berenberg United States 19 829 341 207 191 188 63 1.7k
Peter T. Silberstein United States 21 740 0.9× 319 0.9× 103 0.5× 172 0.9× 165 0.9× 172 1.8k
Dirk Schrijvers Belgium 21 800 1.0× 337 1.0× 373 1.8× 216 1.1× 74 0.4× 62 2.3k
David M. Mintzer United States 22 545 0.7× 477 1.4× 402 1.9× 439 2.3× 173 0.9× 60 2.3k
D. B. Thomas United States 26 834 1.0× 377 1.1× 118 0.6× 174 0.9× 260 1.4× 73 2.5k
Hongbo Yang United States 24 443 0.5× 256 0.8× 207 1.0× 326 1.7× 113 0.6× 136 1.9k
Ahmet Alacacıoğlu Türkiye 25 948 1.1× 369 1.1× 204 1.0× 264 1.4× 86 0.5× 159 2.0k
Alberto Lopes United Kingdom 39 941 1.1× 363 1.1× 160 0.8× 226 1.2× 166 0.9× 119 3.9k
Daniel G. Miller United States 24 1.1k 1.3× 413 1.2× 188 0.9× 223 1.2× 494 2.6× 81 2.5k
Laura Giordano Italy 31 982 1.2× 873 2.6× 161 0.8× 387 2.0× 519 2.8× 165 3.3k
Alexandra Easson Canada 22 730 0.9× 262 0.8× 123 0.6× 146 0.8× 189 1.0× 65 1.8k

Countries citing papers authored by Jeffrey L. Berenberg

Since Specialization
Citations

This map shows the geographic impact of Jeffrey L. Berenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey L. Berenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey L. Berenberg more than expected).

Fields of papers citing papers by Jeffrey L. Berenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey L. Berenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey L. Berenberg. The network helps show where Jeffrey L. Berenberg may publish in the future.

Co-authorship network of co-authors of Jeffrey L. Berenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey L. Berenberg. A scholar is included among the top collaborators of Jeffrey L. Berenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey L. Berenberg. Jeffrey L. Berenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Stearns, Vered, Opeyemi A. Jegede, Victor T. Chang, et al.. (2024). A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11. Clinical Cancer Research. 30(13). 2709–2718. 4 indexed citations
3.
4.
Desmond, Daniel, et al.. (2023). Racial and ethnic differences in tumor characteristics among endometrial cancer patients in an equal-access healthcare population. Cancer Causes & Control. 34(11). 1017–1025. 9 indexed citations
5.
Berenberg, Jeffrey L., et al.. (2023). Pembrolizumab Induced Calcitriol-Mediated Hypercalcemia. Case Reports in Nephrology. 2023. 1–3. 1 indexed citations
6.
Kimmick, Gretchen, Mina S. Sedrak, Grant R. Williams, et al.. (2022). Infrastructure to Support Accrual of Older Adults to National Cancer Institute Clinical Trials. JNCI Monographs. 2022(60). 151–158. 2 indexed citations
7.
Acoba, Jared D., Ken D. Sumida, & Jeffrey L. Berenberg. (2022). Overcoming racial disparities in cancer clinical trial enrollment of Asians and Native Hawaiians. Contemporary Clinical Trials Communications. 28. 100933–100933. 3 indexed citations
8.
Boehmer, Leigh, Brianna Hoffner, Yurii B. Shvetsov, et al.. (2022). Role of Oncology Advanced Practitioners to Enhance Clinical Research. Journal of the Advanced Practitioner in Oncology. 13(2). 107–119. 11 indexed citations
9.
Mohile, Supriya G., Huiwen Xu, Eva Culakova, et al.. (2020). Associations of Uncertainty With Psychological Health and Quality of Life in Older Adults With Advanced Cancer. Journal of Pain and Symptom Management. 61(2). 369–376.e1. 40 indexed citations
10.
Berenberg, Jeffrey L., et al.. (2017). Metronidazole caused profound drug‐induced immune thrombocytopenia. Clinical Case Reports. 6(1). 206–208. 4 indexed citations
11.
Kleckner, Ian R., Charles Kamen, Jennifer S. Gewandter, et al.. (2017). Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Supportive Care in Cancer. 26(4). 1019–1028. 216 indexed citations
12.
Gonsalves, Wilson I., Michelle R. Mahoney, Daniel J. Sargent, et al.. (2014). Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147. JNCI Journal of the National Cancer Institute. 106(7). 127 indexed citations
13.
Bantum, Erin O’Carroll, Cheryl L. Albright, Kami K. White, et al.. (2014). Surviving and Thriving With Cancer Using a Web-Based Health Behavior Change Intervention: Randomized Controlled Trial. Journal of Medical Internet Research. 16(2). e54–e54. 97 indexed citations
14.
Berenberg, Jeffrey L., et al.. (2011). UH Cancer Center Hotline: Recruiting cancer survivors for an online health-behavior change intervention: are different strategies more beneficial?. PubMed. 70(10). 222–3. 9 indexed citations
15.
Marshall, M. Ernest, Catherine M. Tangen, Jeffrey L. Berenberg, et al.. (1994). Treatment of Advanced Colorectal Carcinoma with 5-Fluorouracil, Leucovorin and Roferon-A®: A Southwest Oncology Study Group Study. PubMed. 9(4). 301–306. 3 indexed citations
16.
Berenberg, Jeffrey L., Catherine M. Tangen, John S. Macdonald, Bart Barlogie, & Leslie R. Laufman. (1993). VM-26 in gastric cancer. Investigational New Drugs. 11(4). 333–334. 2 indexed citations
17.
Zidar, Bernard L., et al.. (1992). A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A southwest oncology group study. Cancer. 70(10). 2547–2551. 34 indexed citations
18.
Enzenauer, Raymond J., et al.. (1990). Microangiopathic Hemolytic Anemia as the Initial Manifestation of Porcine Valve Failure. Southern Medical Journal. 83(8). 912–917. 5 indexed citations
19.
Enzenauer, Raymond J., Jeffrey L. Berenberg, & Janice Campbell. (1990). Progressive warfarin anticoagulation in protein C deficiency: A therapeutic strategy. The American Journal of Medicine. 88(6). 697–698. 12 indexed citations
20.
Smith, Carol G., Ramona G. Almirez, Jeffrey L. Berenberg, & Ricardo H. Asch. (1983). Tolerance Develops to the Disruptive Effects of Δ 9 -Tetrahydrocannabinol on Primate Menstrual Cycle. Science. 219(4591). 1453–1455. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter T. Silberstein Breakdown of academic impact, for papers by Dirk Schrijvers Breakdown of academic impact, for papers by David M. Mintzer Breakdown of academic impact, for papers by D. B. Thomas Breakdown of academic impact, for papers by Hongbo Yang Breakdown of academic impact, for papers by Ahmet Alacacıoğlu Breakdown of academic impact, for papers by Alberto Lopes Breakdown of academic impact, for papers by Daniel G. Miller Breakdown of academic impact, for papers by Laura Giordano Breakdown of academic impact, for papers by Alexandra Easson
Rankless by CCL
2026